Abstract:Life expectancy has drastically increased over the last few decades worldwide, with important social and medical burdens and costs. To stay healthy longer and to avoid chronic disease have become essential issues. Organismal aging is a complex process that involves progressive destruction of tissue functionality and loss of regenerative capacity. One of the most important aging hallmarks is cellular senescence, which is a stable state of cell cycle arrest that occurs in response to cumulated cell stresses and damages. Cellular senescence is a physiological mechanism that has both beneficial and detrimental consequences. Senescence limits tumorigenesis, lifelong tissue damage, and is involved in different biological processes, such as morphogenesis, regeneration, and wound healing. However, in the elderly, senescent cells increasingly accumulate in several organs and secrete a combination of senescence associated factors, contributing to the development of various age-related diseases, including cancer. Several studies have revealed major molecular pathways controlling the senescent phenotype, as well as the ones regulating its interactions with the immune system. Attenuating the senescence-associated secretory phenotype (SASP) or eliminating senescent cells have emerged as attractive strategies aiming to reverse or delay the onset of aging diseases. Here, we review current senotherapies designed to suppress the deleterious effect of SASP by senomorphics or to selectively kill senescent cells by "senolytics" or by immune system-based approaches. These recent investigations are promising as radical new controls of aging pathologies and associated multimorbidities.

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics

Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging

Targeting senescent cells for vascular aging and related diseases

Endothelial Cell Senescence and Age-Related Vascular Diseases

Endothelial Senescence and the Chronic Vascular Diseases: Challenges and Therapeutic Opportunities in Atherosclerosis

Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy

Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases

Therapeutic opportunities for senolysis in cardiovascular disease

Targeting vascular senescence in cardiovascular disease with aging

From Macro- to Micro-Vasculature and Its Implications on Cardiovascular Health

Targeting senescent cells in atherosclerosis: Pathways to novel therapies

Potential Clinical Implications of Senotherapies for Cardiovascular Disease

Targeting Senescent Cells for a Healthier Longevity: the Roadmap for an Era of Global Aging

Endothelial Cell Aging: How miRNAs Contribute?

Understanding the Intricacies of Cellular Senescence in Atherosclerosis: Mechanisms and Therapeutic Implications

Targeting Molecular Mechanism of Vascular Smooth Muscle Senescence Induced by Angiotensin II, A Potential Therapy via Senolytics and Senomorphics

Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities

Senescence as a therapeutic target in cancer and age-related diseases

Senescent endothelial cells: a potential target for diabetic retinopathy

Endothelial Cell Senescence Contributes to Pathological Retinal Angiogenesis

Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies